An observational study in Keloid Scar Following Surgery, Scars, Hypertrophic and Scar Keloid, sponsored by University of Zurich. Recruiting at 1 site in Switzerland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-02-07.
Sponsored by University of Zurich · Observational
Measuring the volumes of hypertrophic scars and keloids, two specific kind of scars, over different points in time in patients who have undergone surgery and evaluate 3D-cameras as a possible measuring and documenting tool including volumetry.
The objective of this study is to utilize a 3D camera to measure the volumes of hypertrophic scars and keloids in patients at specified time points. The time points for measurement include day 0, as well as 3, 6, and 12 months. The 3D camera will be evaluated for their efficacy in measuring and documenting the volumes of the scars. This evaluation will include volumetry, which is the measurement of the three-dimensional space occupied by an object.
129 studies on the registry are indexed under Cicatrix, Hypertrophic; 31 are open to participants now.
This study's planned enrollment of 20 is below the median of 30 across 13 observational studies indexed under Cicatrix, Hypertrophic.
Browse Cicatrix, Hypertrophic studies →University of Zurich is the lead sponsor of 1,049 studies on the registry; 133 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients with hypertrophic scars or keloids of the University Hospital Zurich
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
3D-Pictures will be taken of hypertrophic scars and keloids to document them.
Measurability
The objective of this study is to determine the feasibility of utilizing 3D cameras to accurately measure hypertrophic scars and keloids. The primary outcome of this study is the measurement of the volumes of hypertrophic scars in cubic millimeters (equivalent to milliliters) over a period of one year. This will allow for an evaluation of the accuracy of 3D photography and for the observation of any potential changes.
Time frame: Day 0, Month 3, 6 and 12
Started Jan 2025 (actual). Primary completion is estimated for Sep 2025, 8 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.